Let’s accelerate metastatic breast cancer research together.
MBC Connect is an interactive, web and mobile-friendly patient registry, where you can share information about your MBC disease history, experiences, and quality of life.
New Study Shows a Decline in the Incidence of Recurrent Metastatic Breast Cancer Over Time
but no Improvement in Survival
New York, NY (February 1, 2019) A retrospective analysis – reported in the journal Breast Cancer Research and Treatment, by Judith Malmgren, PhD, and co-authors – studied 8292 women with stage I-III invasive breast cancer, 964 of whom (11.6%) were later diagnosed with recurrent metastatic breast cancer (rMBC). The authors found a significant decline in rMBC over time, but no increase in survival. Survival after an rMBC diagnosis decreased over time, from 23% in the years between 1990 and 1998, to 21% between 1999 and 2004, and to 13% between 2005 and 2011.
VISITto raise awareness of metastatic breast cancer!